14-Oct-2026      21:34

Sun Pharma to review quarterly results at a board meeting on October 30, 2026

Sun Pharmaceutical Industries Limited will hold a board meeting on Friday, October 30, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing. The trading window for the company's securities was closed on Thursday, October 1, 2026, and will remain closed until Sunday, November 1, 2026, following the results’ declaration.

News source: Capital Market - Live News